Cardiovascular outcomes among HIV-infected veterans receiving atazanavir

OBJECTIVE: Patients with HIV infection have an increased risk of cardiovascular disease compared with uninfected individuals. Antiretroviral therapy with atazanavir (ATV) delays progression of atherosclerosis markers; whether this reduces cardiovascular disease event risk compared with other antiret...

Descripción completa

Detalles Bibliográficos
Autores principales: LaFleur, Joanne, Bress, Adam P., Rosenblatt, Lisa, Crook, Jacob, Sax, Paul E., Myers, Joel, Ritchings, Corey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603981/
https://www.ncbi.nlm.nih.gov/pubmed/28692532
http://dx.doi.org/10.1097/QAD.0000000000001594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603981/
https://www.ncbi.nlm.nih.gov/pubmed/28692532
http://dx.doi.org/10.1097/QAD.0000000000001594

Ejemplares similares